FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385320908> ?p ?o ?g. }

• W4385320908 endingPage "4432" @default.
• W4385320908 startingPage "4416" @default.
• W4385320908 abstract "The association between diabetes mellitus (DM) and the increased risk and progression of cholangiocarcinoma (CCA) has been reported with unclear underlying mechanisms. Previous studies showed that γ-aminobutyric acid (GABA) B2 receptor (GABBR2) was upregulated in CCA cells cultured in high glucose (HG) conditions. Roles of GABA receptors in CCA progression have also been studied, but their association with DM and hyperglycemia in CCA remains unclarified.To investigate the effects of hyperglycemia on GABBR2 expression and the potential use of GABBR2 as a CCA therapeutic target.CCA cells, KKU-055 and KKU-213A, were cultured in Dulbecco Modified Eagle's Medium supplemented with 5.6 mmol/L (normal glucose, NG) or 25 mmol/L (HG) glucose and assigned as NG and HG cells, respectively. GABBR2 expression in NG and HG cells was investigated using real-time quantitative polymerase chain reaction and western blot. Expression and localization of GABBR2 in CCA cells were determined using immunocytofluorescence. GABBR2 expression in tumor tissues from CCA patients with and without DM was studied using immunohistochemistry, and the correlations of GABBR2 with the clinicopathological characteristics of patients were analyzed using univariate analysis. Effects of baclofen, a GABA-B receptor agonist, on CCA cell proliferation and clonogenicity were tested using the MTT and clonogenic assays. Phospho-kinases arrays were used to screen the affected signaling pathways after baclofen treatment, and the candidate signaling molecules were validated using the public transcriptomic data and western blot.GABBR2 expression in CCA cells was induced by HG in a dose- and time-dependent manner. CCA tissues from patients with DM and hyperglycemia also showed a significantly higher GABBR2 expression compared with tumor tissues from those with euglycemia (P < 0.01). High GABBR2 expression was significantly associated with a poorer non-papillary histological subtype but with smaller sizes of CCA tumors (P < 0.05). HG cells of both tested CCA cell lines were more sensitive to baclofen treatment. Baclofen significantly suppressed the proliferation and clonogenicity of CCA cells in both NG and HG conditions (P < 0.05). Phospho-kinase arrays suggested glycogen synthase kinase 3 (GSK3), β-catenin, and the signal transducer and activator of transcription 3 (STAT3) as candidate signaling molecules under the regulation of GABBR2, which were verified in NG and HG cells of the individual CCA cell lines. Cyclin D1 and c-Myc, the common downstream targets of GSK3/β-catenin and STAT3 involving cell proliferation, were accordingly downregulated after baclofen treatment.GABBR2 is upregulated by HG and holds a promising role as a therapeutic target for CCA regardless of the glucose condition." @default.
• W4385320908 created "2023-07-28" @default.
• W4385320908 creator A5003446927 @default.
• W4385320908 creator A5015397484 @default.
• W4385320908 creator A5027417160 @default.
• W4385320908 creator A5033796964 @default.
• W4385320908 creator A5037132083 @default.
• W4385320908 creator A5040927651 @default.
• W4385320908 creator A5042545433 @default.
• W4385320908 creator A5054499877 @default.
• W4385320908 creator A5075148941 @default.
• W4385320908 creator A5080375096 @default.
• W4385320908 creator A5090293918 @default.
• W4385320908 date "2023-07-28" @default.
• W4385320908 modified "2023-10-01" @default.
• W4385320908 title "γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus" @default.
• W4385320908 cites W1537029917 @default.
• W4385320908 cites W1825423094 @default.
• W4385320908 cites W1965341086 @default.
• W4385320908 cites W1994296775 @default.
• W4385320908 cites W2033522521 @default.
• W4385320908 cites W2045295593 @default.
• W4385320908 cites W2047670144 @default.
• W4385320908 cites W2056226546 @default.
• W4385320908 cites W2076990511 @default.
• W4385320908 cites W2079297432 @default.
• W4385320908 cites W2104195235 @default.
• W4385320908 cites W2118258530 @default.
• W4385320908 cites W2124014081 @default.
• W4385320908 cites W2143819289 @default.
• W4385320908 cites W2161815207 @default.
• W4385320908 cites W2227139775 @default.
• W4385320908 cites W2594279019 @default.
• W4385320908 cites W2606457456 @default.
• W4385320908 cites W2607129810 @default.
• W4385320908 cites W2619384557 @default.
• W4385320908 cites W271304362 @default.
• W4385320908 cites W2724543993 @default.
• W4385320908 cites W2810636912 @default.
• W4385320908 cites W2895487520 @default.
• W4385320908 cites W2973596517 @default.
• W4385320908 cites W2983229458 @default.
• W4385320908 cites W2989425431 @default.
• W4385320908 cites W2991355171 @default.
• W4385320908 cites W3012732786 @default.
• W4385320908 cites W3038323468 @default.
• W4385320908 cites W3046945197 @default.
• W4385320908 cites W3066839050 @default.
• W4385320908 cites W3085041883 @default.
• W4385320908 cites W3089150312 @default.
• W4385320908 cites W3092490320 @default.
• W4385320908 cites W3097724498 @default.
• W4385320908 cites W3124947798 @default.
• W4385320908 cites W3131301900 @default.
• W4385320908 cites W3133939649 @default.
• W4385320908 cites W3134264747 @default.
• W4385320908 cites W3163960069 @default.
• W4385320908 cites W3168592928 @default.
• W4385320908 cites W3187567340 @default.
• W4385320908 cites W3201361098 @default.
• W4385320908 cites W4211113203 @default.
• W4385320908 cites W4211189181 @default.
• W4385320908 cites W4302010920 @default.
• W4385320908 cites W4306912056 @default.
• W4385320908 cites W4311263986 @default.
• W4385320908 doi "https://doi.org/10.3748/wjg.v29.i28.4416" @default.
• W4385320908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37576707" @default.
• W4385320908 hasPublicationYear "2023" @default.
• W4385320908 type Work @default.
• W4385320908 citedByCount "1" @default.
• W4385320908 countsByYear W43853209082023 @default.
• W4385320908 crossrefType "journal-article" @default.
• W4385320908 hasAuthorship W4385320908A5003446927 @default.
• W4385320908 hasAuthorship W4385320908A5015397484 @default.
• W4385320908 hasAuthorship W4385320908A5027417160 @default.
• W4385320908 hasAuthorship W4385320908A5033796964 @default.
• W4385320908 hasAuthorship W4385320908A5037132083 @default.
• W4385320908 hasAuthorship W4385320908A5040927651 @default.
• W4385320908 hasAuthorship W4385320908A5042545433 @default.
• W4385320908 hasAuthorship W4385320908A5054499877 @default.
• W4385320908 hasAuthorship W4385320908A5075148941 @default.
• W4385320908 hasAuthorship W4385320908A5080375096 @default.
• W4385320908 hasAuthorship W4385320908A5090293918 @default.
• W4385320908 hasBestOaLocation W43853209081 @default.
• W4385320908 hasConcept C104317684 @default.
• W4385320908 hasConcept C117262875 @default.
• W4385320908 hasConcept C126322002 @default.
• W4385320908 hasConcept C127561419 @default.
• W4385320908 hasConcept C134018914 @default.
• W4385320908 hasConcept C1491633281 @default.
• W4385320908 hasConcept C153911025 @default.
• W4385320908 hasConcept C170493617 @default.
• W4385320908 hasConcept C185592680 @default.
• W4385320908 hasConcept C204232928 @default.
• W4385320908 hasConcept C2776415932 @default.
• W4385320908 hasConcept C2778938600 @default.
• W4385320908 hasConcept C502942594 @default.
• W4385320908 hasConcept C55493867 @default.

• next